SYT1 and tuberculosis: In antiretroviral therapy, rs199650082 of nucleus signaling-1 (ERN1) is significantly related to DILI, while in antiretroviral therapy combined with anti-tuberculosis therapy, transcriptional variation of synaptotagmin 1 (Syt1) rs4842407 is associated with DILI (Petros et al., 2017).